CRUK–ARR Radiation Research Conference 2023

We are delighted to be partnering with the Association for Radiation Research to develop a three-day conference which will tackle some of the biggest challenges in radiotherapy.

Our intention is to provide a stimulating environment where scientists from the CRUK RadNet network and wider international radiation research community can come together to showcase new discoveries, spark new collaborations, and create the synergy needed to accelerate progress for patients.

Learning objectives

Our multidisciplinary programme will include sessions covering the whole spectrum of radiation research from basic science through translational and clinical studies, providing the attendees with knowledge, tools and techniques to apply to their own research.

There will be ample time throughout the conference to network with peers, view posters and continue thought-provoking conversations outside of the agenda.

Audience

This event is relevant for all academics and scientists across the radiation research pipeline, and in all career stages.

There will be opportunities throughout the conference to network with peers, view posters and continue thought-provoking conversations outside of the agenda. Join us and be part of the conversation for change!

Conference scientific committee

• Anthony Chalmers, School of Cancer Science, University of Glasgow
• Charlotte Coles, Department of Oncology, University of Cambridge
• Kevin Harrington, Division of Radiotherapy and Imaging, The Institute of Cancer Research
• Karen Kirkby, Division of Cancer Science, University of Manchester
• Jason Parsons, Institute of Cancer and Genomic Sciences, University of Birmingham
• Chris Talbot, University of Leicester

Abstracts

All attendees are eligible to submit a poster abstract.
 
Deadline for abstracts is 7 April 2023
Applicants will be notified of acceptance from 24 April 2023
The presenting author of the abstract must register and pay the registration fee.

Be part of our Future Leaders session

COVID-19 guidance

The health and safety of our attendees and those you work with remains our highest priority. We will continue to closely monitor developments relating to COVID-19 and review guidance from government bodies. Further information and advice will be emailed to registered attendees ahead of the event.